# reload+after+2024-01-22 20:45:32.435940
address1§Fitzwilliam Court
address2§1st Floor Leeson Close
city§Dublin
zip§D02 YW24
country§Ireland
phone§353 1 669 4820
website§https://www.iterumtx.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
fullTimeEmployees§14
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Corey N. Fishman', 'age': 58, 'title': 'President, CEO & Director', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 1372710, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Judith M. Matthews', 'age': 53, 'title': 'Chief Financial Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 778817, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Michael W. Dunne M.D.', 'age': 63, 'title': 'Strategic Advisor & Director', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 168148, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Sailaja  Puttagunta M.D.', 'age': 54, 'title': 'Chief Medical Officer', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 755894, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Tom  Loughman Ph.D.', 'title': 'Senior Vice President of Technical Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Louise  Barrett', 'title': 'Senior Vice President of Legal Affairs & Secretary', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Steven I. Aronin M.D.', 'title': 'Senior VP & Head of Clinical Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§2.436
currency§USD
dateShortInterest§1702598400
forwardEps§-3.04
exchange§NCM
quoteType§EQUITY
shortName§Iterum Therapeutics plc
longName§Iterum Therapeutics plc
firstTradeDateEpochUtc§1527255000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§2a47ad90-f2ae-3045-b6c4-2f53ded8d73b
gmtOffSetMilliseconds§-18000000
recommendationMean§3.0
recommendationKey§hold
quickRatio§2.199
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
